Compare · NRGV vs TMO
NRGV vs TMO
Side-by-side comparison of Energy Vault Holdings Inc. (NRGV) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- NRGV operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $174.52B, about 189.4x NRGV ($921.5M).
- Over the past year, NRGV is up 480.9% and TMO is up 14.9% - NRGV leads by 465.9 points.
- TMO has been more active in the news (17 items in the past 4 weeks vs 10 for NRGV).
- TMO has more recent analyst coverage (25 ratings vs 11 for NRGV).
- Company
- Energy Vault Holdings Inc.
- Thermo Fisher Scientific Inc
- Price
- $5.17-5.58%
- $469.56-0.67%
- Market cap
- $921.5M
- $174.52B
- 1M return
- +24.46%
- -1.03%
- 1Y return
- +480.86%
- +14.92%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2021
- News (4w)
- 10
- 17
- Recent ratings
- 11
- 25
Energy Vault Holdings Inc.
Energy Vault Holdings, Inc. develops and sells energy storage solutions. The company offers gravity-based storage systems, including EVx Platform, a scalable, modular product line starting from 40-megawatt hour to multi-gigawatt hours to address grid resiliency needs in shorter durations; Energy Vault Resiliency Center, a scalable, gigawatt hour scale product line designed to address grid resiliency needs to manage energy disruptive climate events; and Energy Vault solutions. Its solutions allow utilities, independent power producers, and large energy users to manage their power portfolios and efficiently dispatch power. Energy Vault Holdings, Inc. is based in Westlake Village, California.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest NRGV
- Director Mandanas Mary Beth was granted 22,026 shares, increasing direct ownership by 6% to 372,864 units (SEC Form 4)
- Director Unwin Stephanie was granted 19,153 shares, increasing direct ownership by 7% to 297,245 units (SEC Form 4)
- Director Paulson Larry was granted 22,026 shares, increasing direct ownership by 4% to 523,794 units (SEC Form 4)
- Director Fariello Theresa M was granted 19,153 shares, increasing direct ownership by 6% to 318,217 units (SEC Form 4)
- Director Hixon Dylan was granted 19,153 shares, increasing direct ownership by 19% to 117,602 units (SEC Form 4)
- Director Ertel Thomas R was granted 22,026 shares, increasing direct ownership by 6% to 387,814 units (SEC Form 4)
- Energy Vault Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Energy Vault Closes Acquisition of 850 MW Energy Storage Portfolio from BayWa r.e. AG, Establishing Immediate Operational Platform to Capture Growth in Japan
- Energy Vault Appoints IPP Industry Vet Cory Magnuson as President of Asset Vault, Announces Expansion of Financing Platform to Support Massive Demand in AI Compute Infrastructure Solutions
- SEC Form NT 10-Q filed by Energy Vault Holdings Inc.
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)